Draper and Bristol-Myers Squibb Ink Toxicity Testing Deal

Draper and Bristol-Myers Squibb Ink Toxicity Testing Deal

Source: 
BioSpace
snippet: 

Draper, based in Cambridge, Massachusetts, signed a tissue model development deal with Bristol-Myers Squibb. The companies will collaborate on developing a unique liver tissue model to screen drugs for toxicity.